share_log

Individual Investors Are China Resources Medical Holdings Company Limited's (HKG:1515) Biggest Owners and Were Rewarded After Market Cap Rose by HK$532m Last Week

Individual Investors Are China Resources Medical Holdings Company Limited's (HKG:1515) Biggest Owners and Were Rewarded After Market Cap Rose by HK$532m Last Week

個人投資者是華潤醫療控股有限公司(HKG: 1515)的最大所有者,在上週市值上漲5.32億港元后獲得了回報
Simply Wall St ·  04/26 18:20

Key Insights

關鍵見解

  • The considerable ownership by individual investors in China Resources Medical Holdings indicates that they collectively have a greater say in management and business strategy
  • The top 6 shareholders own 51% of the company
  • Institutional ownership in China Resources Medical Holdings is 21%
  • 個人投資者對華潤醫療控股的大量所有權表明,他們在管理和業務戰略方面集體擁有更大的發言權
  • 前6名股東擁有公司51%的股份
  • 華潤醫療控股的機構所有權爲21%

Every investor in China Resources Medical Holdings Company Limited (HKG:1515) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 42% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

華潤醫療控股有限公司(HKG: 1515)的每位投資者都應該了解最強大的股東群體。而持有最大份額的群體是擁有42%所有權的個人投資者。也就是說,如果股票上漲,該集團將受益最大(如果出現低迷,則損失最大)。

As a result, individual investors were the biggest beneficiaries of last week's 11% gain.

因此,個人投資者是上週11%漲幅的最大受益者。

Let's take a closer look to see what the different types of shareholders can tell us about China Resources Medical Holdings.

讓我們仔細看看不同類型的股東能告訴我們關於華潤醫療控股的什麼。

ownership-breakdown
SEHK:1515 Ownership Breakdown April 26th 2024
SEHK: 1515 所有權明細 2024 年 4 月 26 日

What Does The Institutional Ownership Tell Us About China Resources Medical Holdings?

關於華潤醫療控股,機構所有權告訴我們什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見指數的回報進行比較。因此,他們通常會考慮收購相關基準指數中包含的大型公司。

As you can see, institutional investors have a fair amount of stake in China Resources Medical Holdings. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at China Resources Medical Holdings' earnings history below. Of course, the future is what really matters.

如你所見,機構投資者持有華潤醫療控股的相當數量的股份。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。如果多家機構同時改變對股票的看法,你可能會看到股價快速下跌。因此,值得在下面查看華潤醫療控股的收益記錄。當然,未來才是真正重要的。

earnings-and-revenue-growth
SEHK:1515 Earnings and Revenue Growth April 26th 2024
SEHK: 1515 2024 年 4 月 26 日的收益和收入增長

Hedge funds don't have many shares in China Resources Medical Holdings. Looking at our data, we can see that the largest shareholder is China Resources Company Limited with 37% of shares outstanding. With 5.0% and 3.4% of the shares outstanding respectively, First Sentier Investors (Australia) IM Ltd and British Columbia Investment Management Corporation are the second and third largest shareholders.

對沖基金在華潤醫療控股的股份不多。從我們的數據來看,我們可以看到最大股東是華潤有限公司,已發行股份的37%。First Sentier Investors(澳大利亞)IM Ltd和不列顛哥倫比亞省投資管理公司分別擁有5.0%和3.4%的已發行股份,是第二和第三大股東。

We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

我們還觀察到,前六名股東佔股票登記冊的一半以上,少數規模較小的股東可以在一定程度上平衡大股東的利益。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

雖然研究公司的機構所有權數據是有意義的,但研究分析師的情緒以了解風向哪個方向吹來也是有意義的。有相當數量的分析師在報道該股,因此了解他們對未來的總體看法可能很有用。

Insider Ownership Of China Resources Medical Holdings

華潤醫療控股的內部所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

不同國家對內部人員的定義可能略有不同,但董事會成員總是計算在內。公司管理層經營業務,但首席執行官將向董事會負責,即使他或她是董事會成員。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部所有權是一件好事。但是,在某些情況下,這使其他股東更難追究董事會對決策的責任。

Our most recent data indicates that insiders own less than 1% of China Resources Medical Holdings Company Limited. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. It appears that the board holds about HK$9.3m worth of stock. This compares to a market capitalization of HK$5.4b. Many tend to prefer to see a board with bigger shareholdings. A good next step might be to take a look at this free summary of insider buying and selling.

我們最新的數據顯示,內部人士擁有華潤醫療控股有限公司不到1%的股份。但是,我們確實注意到,內部人士有可能通過私營公司或其他公司結構獲得間接利益。看來董事會持有價值約930萬港元的股票。相比之下,市值爲54億港元。許多人傾向於看到一個擁有更多股權的董事會。一個不錯的下一步可能是看看這份免費的內幕買入和賣出摘要。

General Public Ownership

一般公有制

The general public, who are usually individual investors, hold a 42% stake in China Resources Medical Holdings. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

公衆通常是個人投資者,持有華潤醫療控股42%的股份。儘管這種所有權規模可能不足以影響對他們有利的政策決定,但它們仍然可以對公司政策產生集體影響。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 37%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們的數據表明,私人公司持有該公司37%的股份。可能值得對此進行更深入的研究。如果關聯方,例如內部人士,在其中一傢俬營公司中擁有權益,則應在年度報告中披露。私營公司也可能在公司中擁有戰略利益。

Next Steps:

後續步驟:

It's always worth thinking about the different groups who own shares in a company. But to understand China Resources Medical Holdings better, we need to consider many other factors. For instance, we've identified 1 warning sign for China Resources Medical Holdings that you should be aware of.

擁有公司股份的不同群體總是值得考慮的。但是,要更好地了解華潤醫療控股,我們需要考慮許多其他因素。例如,我們已經確定了華潤醫療控股的一個警告信號,你應該注意這一點。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果你想了解分析師對未來增長的預測,千萬不要錯過這份關於分析師預測的免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論